TH-287
CAS No. 1609960-30-6
TH-287 ( TH287 )
Catalog No. M12321 CAS No. 1609960-30-6
A potent and selective inhibitor of MTH1 protein with IC50 of 0.8 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 37 | In Stock |
|
5MG | 59 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 178 | In Stock |
|
50MG | 347 | In Stock |
|
100MG | 516 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTH-287
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective inhibitor of MTH1 protein with IC50 of 0.8 nM.
-
DescriptionA potent and selective inhibitor of MTH1 protein with IC50 of 0.8 nM; shows no relevant inhibition for MTH2,NUDT5, NUDT12,NUDT14,NUDT16 and other proteinswith known nucleoside triphosphate pyrophosphatase activity; causees incorporation of oxidized dNTPs in cancer cells, leading to DNA damage, cytotoxicity and therapeutic responses in patient-derived mouse xenografts.
-
SynonymsTH287
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorMTH1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1609960-30-6
-
Formula Weight269.13
-
Molecular FormulaC11H10Cl2N4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 2.6 mg/mL
-
SMILESNC1=NC(C2=CC=CC(Cl)=C2Cl)=CC(NC)=N1
-
Chemical Name2,4-Pyrimidinediamine, 6-(2,3-dichlorophenyl)-N4-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gad H, et al. Nature. 2014 Apr 10;508(7495):215-21.
2. Wang M, et al. Sci Rep. 2017 Jan 11;7:40557.
3. Kawamura T, et al. Sci Rep. 2016 May 23;6:26521.
2. Wang M, et al. Sci Rep. 2017 Jan 11;7:40557.
3. Kawamura T, et al. Sci Rep. 2016 May 23;6:26521.
molnova catalog
related products
-
L82-G17
L82-G17 is an uncompetitive LigI-selective inhibitor in human cells with utility as a probe of the catalytic activity and cellular functions of LigI.
-
JH-RE-06
JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), which targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 also improves chemotherapy.
-
NITD-2
NITD-2 is a dengue virus (DENV) polymerase inhibitor, inhibits the DENV RdRp-mediated RNA elongation.?